Vikings unwittingly made their swords stronger by trying to imbue them with spirits

They didn't know it, but the rituals of Iron Age Scandinavians turned their iron into steel.

Viking
Shutterstock
  • Iron Age Scandinavians only had access to poor quality iron, which put them at a tactical disadvantage against their neighbors.
  • To strengthen their swords, smiths used the bones of their dead ancestors and animals, hoping to transfer the spirit into their blades.
  • They couldn't have known that in so doing, they actually were forging a rudimentary form of steel.

Science fiction author Arthur C. Clarke wrote that "any sufficiently advanced technology is indistinguishable from magic." While we usually extend this to the future, the same was true of the past. In much of ancient history, the line between technology and ritual was thin. Smiths were something in between craftsman and magicians, in possession of secret, esoteric knowledge. In early Iron Age Scandinavia, for instance, just before the advent of the Viking Age, smiths discovered a ritual that enabled them to impart the steely strength of their ancestors and animals into their weapons.

This was a crucial transformation for Scandinavians; the majority of iron they had access to was bog iron. Bacteria in bogs oxidize trace amounts of iron to gain energy and, in so doing, concentrate the iron, enabling its collection for smithing. However, the resulting iron is impure and soft, which was a big problem for the Scandinavians. Conflicts could easily be decided by the side that had the better equipment, and Iron Age Scandinavia was full of conflict.

Either against the Romans, neighboring warlords, or Christian settlements, survival depended upon defending against conflict or engaging in it.

Scandinavian smiths discovered that the bones of the dead could grant them an edge. Numerous forges scattered across Scandinavia contain the remains of animal and human bones — by incorporating the remains of the dead, their spirits could be transferred into a blade, making it stronger and more durable.

Mistaking technology for magic

Incorporating bones into the smithing process did in fact make Scandinavian swords stronger, but it wasn't magic — it was technology. What ancient smiths could not have realized is that they were in fact mixing their bog iron with carbon to make a rudimentary form of steel.

Carbon is present in all organic matter, and the same is true for bones. By burning bones in a low-oxygen environment, ancient smiths would have produced bone-coal, much in the same way that burning wood in a low-oxygen environment makes charcoal. Researchers have conducted experiments that recreate the process of forging a sword using bog iron and bone-coal; the carbon from the bones can penetrate up to 3 millimeters deep into bog iron, enough to significantly strengthen the sword.

Evidence of ritual smithing

Snartemo Sword

The Snartemo sword, found in a Norwegian tomb, dates to 500 AD. This would have been around the time that smiths were using bone-coal to strengthen their iron.

Wikimedia Commons

While we have no written records of this process occurring, we do know that the remains of ancestors were highly sought after. Archaeologist Ing-Marie Back Danielsson writes,

"Through archaeological excavations it is evident that burial mounds were opened shortly after their construction […] anything from a few years to decades after initial burial. Terje Gansum […] has suggested that these re-excavations of mounds were for the purposeful retrieval of bones. In this way, ancestral power was literally appropriated for occasions such as carbonizing iron, where bone coal was a necessary ingredient. Brendalsmo and Røthe […] have interpreted these retrievals or re-excavations as the possible recovery of items with magical power and those associated with necromancy."

From all of the bones found around smithies, it's clear that smiths used bones in some capacity. What's more, ritualistically incorporating the bones of dead ancestors into smithing fits well with what we understand about ancient smithing practices.

Throughout the world's ancient cultures, the forge was seen as female, and the smith was its metaphorical husband. Weaponry and tools were birthed from forges, rather than made. By using the bones, the "spirit" of animals or humans, Scandinavian smiths were, in a sense, making a new being. An ancient Scandinavian collection of poetry called the Poetic Edda describes many swords that had names, some of which even had what one might call a spirit — some could speak, sing, provide guidance, or cause misfortune to their wielder. While we can say with some confidence that Scandinavian blades weren't excellent conversationalists, ancient smiths were, in a sense, filling them with life — that of a famous warrior, a powerful animal, or the wielder's own deceased ancestors, and in doing so, they were making steel.

A new study says it's okay to eat red meat. An immediate uproar follows.

Even before publication, health agencies were asking the journal not to publish the research.

Photo by Isa Terli/Anadolu Agency/Getty Images

Surprising Science
  • A new study in the Annals of Internal Medicine found little correlation between red meat consumption and health problems.
  • A number of organizations immediately contested the evidence, claiming it to be based on an irrelevant system of analysis.
  • Beef and dairy production is one of the leading drivers of climate change, forcing humans to weigh personal health against the environment.
Keep reading Show less

CRISPR therapy cures first genetic disorder inside the body

It marks a breakthrough in using gene editing to treat diseases.

Credit: National Cancer Institute via Unsplash
Technology & Innovation

This article was originally published by our sister site, Freethink.

For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

We can overcome one of the biggest challenges with applying CRISPR clinically.

—JENNIFER DOUDNA

"This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

"While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

This is a wonderful day for the future of gene-editing as a medicine.

—FYODOR URNOV

If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

"This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."

UFOs: US intelligence report finds no aliens but plenty of unidentified flying objects

A new government report describes 144 sightings of unidentified aerial phenomena.

Photo by Albert Antony on Unsplash
Surprising Science

On June 25, 2021, the Office of the Director of National Intelligence released a much-anticipated report on UFOs to Congress.

Keep reading Show less
Quantcast